Revenue
3.1 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 3102000 USD Source
Annual consolidated revenue for 2025: about USD 16.58M, using the latest reported figures. The previous period, 2024, was about USD 14.17M.
3.1 million USD
2026 Q2 · USD
-542.91%
2026 Q2 · %
-9.57 million USD
2026 Q2 · USD
-9.58 million USD
2026 Q2 · USD
26075000 USD
63976977 shares
2.14% · 1.34 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
14.2 million USD
2025-07-01 – 2026-06-30
-68 million USD
2025-07-01 – 2026-06-30
-43.4 million USD
2025-07-01 – 2026-06-30
854 thousand USD
2025-07-01 – 2026-06-30
-44.2 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 14.17 million
–
Current period
USD 16.58 million
–
16578000 − 14170000 = 2408000 USD
14170000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source16578000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 86.6 million
–
Current period
−USD 73.6 million
–
-73600000 − -86599000 = 12999000 USD
-86599000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-73600000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 46.11 million
–
Current period
−USD 44.45 million
–
-44448000 − -46109000 = 1661000 USD
-46109000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-44448000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 3.58 million
–
Current period
USD 1.8 million
–
1797000 − 3584000 = -1787000 USD
3584000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1797000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 656000 | 34305000 Derived | -33649000 | -874000 Derived | -32775000 | -25362000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 6617000 | 78090000 Derived | -71473000 | -304000 Derived | -71169000 | -53269000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 15493000 | 112728000 Derived | -97235000 | -4269000 Derived | -92966000 | -71045000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 16661000 | 120124000 Derived | -103463000 | -17186000 Derived | -86277000 | -66374000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 14170000 | 114271000 Derived | -100101000 | -13502000 Derived | -86599000 | -49693000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 16578000 | 94570000 Derived | -77992000 | -4392000 Derived | -73600000 | -46245000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 656000 |
|
| 2021 | Revenue | 6617000 |
|
| 2022 | Revenue | 15493000 |
|
| 2023 | Revenue | 16661000 |
|
| 2024 | Revenue | 14170000 |
|
| 2025 | Revenue | 16578000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 908.7% |
|
| 2022 | Year over year | 134.1% |
|
| 2023 | Year over year | 7.5% |
|
| 2024 | Year over year | -15% |
|
| 2025 | Year over year | 17% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -5,129.4% |
|
| 2021 | Operating margin | -1,080.1% |
|
| 2022 | Operating margin | -627.6% |
|
| 2023 | Operating margin | -621% |
|
| 2024 | Operating margin | -706.4% |
|
| 2025 | Operating margin | -470.5% |
|
| 2020 | Net margin | -4,996.2% |
|
| 2021 | Net margin | -1,075.5% |
|
| 2022 | Net margin | -600.1% |
|
| 2023 | Net margin | -517.8% |
|
| 2024 | Net margin | -611.1% |
|
| 2025 | Net margin | -444% |
|
| 2020 | Free cash flow margin | -3,866.2% |
|
| 2021 | Free cash flow margin | -805% |
|
| 2022 | Free cash flow margin | -458.6% |
|
| 2023 | Free cash flow margin | -398.4% |
|
| 2024 | Free cash flow margin | -350.7% |
|
| 2025 | Free cash flow margin | -279% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -20828000 |
|
| 2021 | Operating cash flow | -46347000 |
|
| 2022 | Operating cash flow | -60780000 |
|
| 2023 | Operating cash flow | -59065000 |
|
| 2024 | Operating cash flow | -46109000 |
|
| 2025 | Operating cash flow | -44448000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | -25362000 |
|
| 2021 | Free cash flow | -53269000 |
|
| 2022 | Free cash flow | -71045000 |
|
| 2023 | Free cash flow | -66374000 |
|
| 2024 | Free cash flow | -49693000 |
|
| 2025 | Free cash flow | -46245000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 2.4% |
|
| 2021 | Liabilities / assets | 6.7% |
|
| 2022 | Liabilities / assets | 8.4% |
|
| 2023 | Liabilities / assets | 9% |
|
| 2024 | Liabilities / assets | 10.6% |
|
| 2025 | Liabilities / assets | 12.4% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 53.51× |
|
| 2021 | Current assets / current liabilities | 30.67× |
|
| 2022 | Current assets / current liabilities | 34.57× |
|
| 2023 | Current assets / current liabilities | 25× |
|
| 2024 | Current assets / current liabilities | 16.53× |
|
| 2025 | Current assets / current liabilities | 12.84× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 32.78 million Exact valueExact value: -32775000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20.83 million Exact valueExact value: -20828000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.53 million Exact valueExact value: 4534000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.36 million Calculation and evidence-20828000 − 4534000 USD Exact free cash flow: -25362000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 71.17 million Exact valueExact value: -71169000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 46.35 million Exact valueExact value: -46347000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.92 million Exact valueExact value: 6922000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 53.27 million Calculation and evidence-46347000 − 6922000 USD Exact free cash flow: -53269000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 92.97 million Exact valueExact value: -92966000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 60.78 million Exact valueExact value: -60780000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 10.27 million Exact valueExact value: 10265000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 71.05 million Calculation and evidence-60780000 − 10265000 USD Exact free cash flow: -71045000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 86.28 million Exact valueExact value: -86277000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.07 million Exact valueExact value: -59065000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7.31 million Exact valueExact value: 7309000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 66.37 million Calculation and evidence-59065000 − 7309000 USD Exact free cash flow: -66374000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 86.6 million Exact valueExact value: -86599000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 46.11 million Exact valueExact value: -46109000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.58 million Exact valueExact value: 3584000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49.69 million Calculation and evidence-46109000 − 3584000 USD Exact free cash flow: -49693000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 73.6 million Exact valueExact value: -73600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 44.45 million Exact valueExact value: -44448000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.8 million Exact valueExact value: 1797000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 46.25 million Calculation and evidence-44448000 − 1797000 USD Exact free cash flow: -46245000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
30 filings · 1,880 latest values · 1,880 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001726445, 1726445, SEER, edgar:1726445
Also known as SEER, INC., Seer Biosciences, Inc., Seer, Inc.